Published in J Natl Cancer Inst on May 18, 2005
Thyroid Cancer Detection by Ultrasound Among Residents Ages 18 Years and Younger in Fukushima, Japan: 2011 to 2014. Epidemiology (2016) 6.47
The linear no-threshold relationship is inconsistent with radiation biologic and experimental data. Radiology (2009) 3.25
I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ Health Perspect (2011) 2.95
Children's exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations. Pediatr Radiol (2008) 2.40
Gene expression signatures that predict radiation exposure in mice and humans. PLoS Med (2007) 2.38
The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. J Clin Endocrinol Metab (2013) 2.17
Cancer risks after radiation exposure in middle age. J Natl Cancer Inst (2010) 2.05
Occupation and thyroid cancer. Occup Environ Med (2014) 2.00
Calculation of electron dose to target cells in a complex environment by Monte Carlo code "CELLDOSE". Eur J Nucl Med Mol Imaging (2008) 1.97
Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident. Br J Cancer (2010) 1.93
The thyroid status of children and adolescents in Fukushima Prefecture examined during 20-30 months after the Fukushima nuclear power plant disaster: a cross-sectional, observational study. PLoS One (2014) 1.85
The Chernobyl accident--an epidemiological perspective. Clin Oncol (R Coll Radiol) (2011) 1.82
Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res (2010) 1.68
Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia. Am J Epidemiol (2007) 1.58
Ultrasonography survey and thyroid cancer in the Fukushima Prefecture. Radiat Environ Biophys (2014) 1.38
Thyroid cancer gender disparity. Future Oncol (2010) 1.36
Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol (2013) 1.31
Observations on the Chernobyl Disaster and LNT. Dose Response (2010) 1.28
Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers. J Clin Invest (2013) 1.27
Radiation-induced thyroid cancer--what's new? J Natl Cancer Inst (2005) 1.24
A screening study of thyroid cancer and other thyroid diseases among individuals exposed in utero to iodine-131 from Chernobyl fallout. J Clin Endocrinol Metab (2008) 1.18
ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer. Cancer (2013) 1.18
New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin (2013) 1.16
Measures of thyroid function among Belarusian children and adolescents exposed to iodine-131 from the accident at the Chernobyl nuclear plant. Environ Health Perspect (2013) 1.14
Iodine-131 dose dependent gene expression in thyroid cancers and corresponding normal tissues following the Chernobyl accident. PLoS One (2012) 1.12
The chernobyl accident 20 years on: an assessment of the health consequences and the international response. Environ Health Perspect (2006) 1.06
Ultrasound-detected thyroid nodule prevalence and radiation dose from fallout. Radiat Res (2008) 1.05
RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Cancer (2013) 1.04
EANM procedure guidelines for therapy of benign thyroid disease. Eur J Nucl Med Mol Imaging (2010) 1.02
Ionising radiation and cancer risks: what have we learned from epidemiology? Int J Radiat Biol (2009) 0.99
Subclinical hypothyroidism after radioiodine exposure: Ukrainian-American cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident (1998-2000). Environ Health Perspect (2008) 0.97
Risk of thyroid cancer among Chernobyl emergency workers of Russia. Radiat Environ Biophys (2008) 0.95
Reconstruction of radiation doses in a case-control study of thyroid cancer following the Chernobyl accident. Health Phys (2010) 0.94
Overestimation of Chernobyl consequences: biophysical aspects. Radiat Environ Biophys (2009) 0.94
Impact of uncertainties in exposure assessment on estimates of thyroid cancer risk among Ukrainian children and adolescents exposed from the Chernobyl accident. PLoS One (2014) 0.93
Morphologic characteristics of Chernobyl-related childhood papillary thyroid carcinomas are independent of radiation exposure but vary with iodine intake. Thyroid (2008) 0.92
What is New on Thyroid Cancer Biomarkers. Biomark Insights (2008) 0.91
Clinical behavior of radiation-induced thyroid cancer: factors related to recurrence. Thyroid (2009) 0.91
A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas. Br J Cancer (2012) 0.90
Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumors. Endocr Relat Cancer (2011) 0.87
Iodine-131 dose-dependent gene expression: alterations in both normal and tumour thyroid tissues of post-Chernobyl thyroid cancers. Br J Cancer (2013) 0.86
Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests: an update. Radiat Res (2010) 0.85
Endocrine effects of Fukushima: Radiation-induced endocrinopathy. Indian J Endocrinol Metab (2011) 0.85
Accounting for shared and unshared dosimetric uncertainties in the dose response for ultrasound-detected thyroid nodules after exposure to radioactive fallout. Radiat Res (2015) 0.85
Immune response in thyroid cancer: widening the boundaries. Scientifica (Cairo) (2014) 0.84
Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies. Thyroid Res (2015) 0.84
Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian population. PLoS One (2015) 0.83
Thyroid cancer after chernobyl: obfuscated truth. Dose Response (2011) 0.83
Screening effects in risk studies of thyroid cancer after the Chernobyl accident. Radiat Environ Biophys (2009) 0.83
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma. Nat Rev Endocrinol (2016) 0.83
Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl. Eur J Nucl Med Mol Imaging (2011) 0.82
Dose-dependent expression of CLIP2 in post-Chernobyl papillary thyroid carcinomas. Carcinogenesis (2015) 0.82
Prevalence of hyperthyroidism after exposure during childhood or adolescence to radioiodines from the chornobyl nuclear accident: dose-response results from the Ukrainian-American Cohort Study. Radiat Res (2010) 0.82
Thyroid cancer following nuclear tests in French Polynesia. Br J Cancer (2010) 0.82
Re: Risk of thyroid cancer after exposure to (131)I in childhood. J Natl Cancer Inst (2006) 0.81
Prognosis of thyroid nodules in individuals living in the Zhitomir region of Ukraine. PLoS One (2012) 0.81
Radiation signatures in childhood thyroid cancers after the Chernobyl accident: possible roles of radiation in carcinogenesis. Cancer Sci (2015) 0.81
Major Factors Affecting Incidence of Childhood Thyroid Cancer in Belarus after the Chernobyl Accident: Do Nitrates in Drinking Water Play a Role? PLoS One (2015) 0.81
Risk of Thyroid Follicular Adenoma Among Children and Adolescents in Belarus Exposed to Iodine-131 After the Chornobyl Accident. Am J Epidemiol (2015) 0.81
Oncogenic rearrangements driving ionizing radiation-associated human cancer. J Clin Invest (2013) 0.80
Gene expression signature in mouse thyroid tissue after (131)I and (211)At exposure. EJNMMI Res (2015) 0.80
Gene signature of the post-Chernobyl papillary thyroid cancer. Eur J Nucl Med Mol Imaging (2016) 0.80
Radiation-epidemiological studies of thyroid cancer incidence among children and adolescents in the Bryansk oblast of Russia after the Chernobyl accident (1991-2001 follow-up period). Radiat Environ Biophys (2006) 0.80
Papillary thyroid microcarcinoma: incidence and prognostic factors. Eur Arch Otorhinolaryngol (2007) 0.79
Biodistribution of (137)Cs in a mouse model of chronic contamination by ingestion and effects on the hematopoietic system. Radiat Environ Biophys (2010) 0.78
Measurement of the internal dose to families of outpatients treated with 131I for hyperthyroidism. Eur J Nucl Med Mol Imaging (2008) 0.78
Modeling thyroid cancer in the mouse. Horm Metab Res (2009) 0.77
Evaluation of the Relationship between Current Internal 137Cs Exposure in Residents and Soil Contamination West of Chernobyl in Northern Ukraine. PLoS One (2015) 0.77
Methodological extensions of meta-analysis with excess relative risk estimates: application to risk of second malignant neoplasms among childhood cancer survivors treated with radiotherapy. J Radiat Res (2014) 0.76
Genomic copy number analysis of Chernobyl papillary thyroid carcinoma in the Ukrainian-American Cohort. Carcinogenesis (2015) 0.76
The effects of iodine blocking following nuclear accidents on thyroid cancer, hypothyroidism, and benign thyroid nodules: design of a systematic review. Syst Rev (2015) 0.75
The recognition of childhood thyroid cancer as a consequence of the Chernobyl accident: an allegorical tale of our time? J R Soc Med (2007) 0.75
Re: Risk of thyroid cancer after exposure to (131)I in childhood. J Natl Cancer Inst (2006) 0.75
Clusters of adolescent and young adult thyroid cancer in Florida counties. Biomed Res Int (2014) 0.75
Clinical experiences with radiation induced thyroid cancer after chernobyl. Genes (Basel) (2011) 0.75
The hypothalamic-pituitary-thyroid axis in infants and children: protection from radioiodines. J Thyroid Res (2014) 0.75
Impact of Uncertainties in Exposure Assessment on Thyroid Cancer Risk among Persons in Belarus Exposed as Children or Adolescents Due to the Chernobyl Accident. PLoS One (2015) 0.75
Total cancer incidence in relation to 137Cs fallout in the most contaminated counties in Sweden after the Chernobyl nuclear power plant accident: a register-based study. BMJ Open (2016) 0.75
Transcriptional response to 131I exposure of rat thyroid gland. PLoS One (2017) 0.75
Non-thyroid cancer incidence in Belarusian residents exposed to Chernobyl fallout in childhood and adolescence: Standardized Incidence Ratio analysis, 1997-2011. Environ Res (2016) 0.75
Runs of homozygosity and inbreeding in thyroid cancer. BMC Cancer (2016) 0.75
In utero exposure to iodine-131 from Chernobyl fallout and anthropometric characteristics in adolescence. Radiat Res (2014) 0.75
Un-collimated single-photon imaging system for high-sensitivity small animal and plant imaging. Phys Med Biol (2014) 0.75
Review of Factors Related to the Thyroid Cancer Epidemic. Int J Endocrinol (2017) 0.75
Papillary carcinoma of the thyroid gland in a child of thyrotoxicosis patient receiving radioactive iodine therapy: report of a case. Pediatr Surg Int (2008) 0.75
Thyroid cancer following childhood low dose radiation exposure: a pooled analysis of nine cohorts. J Clin Endocrinol Metab (2017) 0.75
Thirty-Five Years of Thyroid Cancer Experience in a Paediatric Population: Incidence Trends in Lithuania between 1980 and 2014. Eur Thyroid J (2016) 0.75
Common genetic variant on 14q13.3 contributes to thyroid cancer susceptibility: evidence based on 12 studies. Mol Genet Genomics (2015) 0.75
"Nuclear" medicine physicians as communicators: their point of view on the aftermath of "nuclear" disaster. Wien Med Wochenschr (2012) 0.75
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest (2005) 5.48
Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med (2004) 4.05
Study protocol for the Fukushima Health Management Survey. J Epidemiol (2012) 3.67
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab (2008) 3.38
Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot (2006) 3.03
Europe is iodine deficient. Lancet (2003) 2.99
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab (2007) 2.74
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol (2008) 2.70
Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid (2008) 2.65
Alkaline pH homeostasis in bacteria: new insights. Biochim Biophys Acta (2005) 2.64
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ (2012) 2.44
Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. J Clin Endocrinol Metab (2003) 2.44
Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks. Environ Health Perspect (2012) 2.42
Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer Sci (2008) 2.39
BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol (2004) 2.21
Three DNA polymerases, recruited by different mechanisms, carry out NER repair synthesis in human cells. Mol Cell (2010) 2.09
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology (2007) 2.08
Ionising radiation and risk of death from leukaemia and lymphoma in radiation-monitored workers (INWORKS): an international cohort study. Lancet Haematol (2015) 2.05
Low plasma ghrelin levels in patients with Helicobacter pylori-associated gastritis. Am J Med (2004) 1.91
Hypervariable loci that enhance the discriminatory ability of newly proposed 15-loci and 24-loci variable-number tandem repeat typing method on Mycobacterium tuberculosis strains predominated by the Beijing family. FEMS Microbiol Lett (2007) 1.83
Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease. Am J Gastroenterol (2004) 1.82
Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab (2004) 1.82
Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. J Clin Endocrinol Metab (2002) 1.81
Acute hepatitis E of a man who consumed wild boar meat prior to the onset of illness in Nagasaki, Japan. Hepatol Res (2005) 1.80
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. J Clin Endocrinol Metab (2004) 1.79
The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem Biophys Res Commun (2007) 1.76
The Mrp system: a giant among monovalent cation/proton antiporters? Extremophiles (2005) 1.75
Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab (2004) 1.75
Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology (2007) 1.73
The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet (2010) 1.72
Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challenge. Clin Chem (2009) 1.71
Estimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accident. Int J Cancer (2006) 1.71
Minimally invasive video-assisted thyroidectomy for papillary carcinoma: a prospective study of its completeness. Surgery (2002) 1.71
Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid (2004) 1.69
A rapid non-radioactive technique for measurement of repair synthesis in primary human fibroblasts by incorporation of ethynyl deoxyuridine (EdU). Nucleic Acids Res (2009) 1.66
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J Clin Endocrinol Metab (2010) 1.63
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. J Clin Endocrinol Metab (2012) 1.62
Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness. Virchows Arch (2005) 1.62
The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol (2013) 1.62
The selective tyrosine kinase inhibitor, STI571, inhibits growth of anaplastic thyroid cancer cells. J Clin Endocrinol Metab (2003) 1.61
Dental x-rays and the risk of thyroid cancer: a case-control study. Acta Oncol (2010) 1.55
Report from the techa river dosimetry review workshop held on 8-10 December 2003 at The State Research Centre Institute of Biophysics, Moscow, Russia. Health Phys (2006) 1.55
Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med (2003) 1.55
Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children. Sleep (2003) 1.54
Risk of cataract after exposure to low doses of ionizing radiation: a 20-year prospective cohort study among US radiologic technologists. Am J Epidemiol (2008) 1.53
Factors related to abstinence in a telephone helpline for smoking cessation. Eur J Public Health (2004) 1.52
Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients. J Clin Endocrinol Metab (2004) 1.52
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. J Clin Endocrinol Metab (2004) 1.52
Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia. Am J Hum Genet (2013) 1.52
Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab (2007) 1.51
Expanding indications for recombinant human TSH in thyroid cancer. Thyroid (2008) 1.49
Estimating historical radiation doses to a cohort of U.S. radiologic technologists. Radiat Res (2006) 1.48
Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology (2003) 1.48
EPI-CT: design, challenges and epidemiological methods of an international study on cancer risk after paediatric and young adult CT. J Radiol Prot (2015) 1.46
Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey. Br J Ophthalmol (2006) 1.45
Low prevalence of the somatic M918T RET mutation in micro-medullary thyroid cancer. Thyroid (2012) 1.45
Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women. High Blood Press Cardiovasc Prev (2012) 1.42
Fallout deposition in the Marshall Islands from Bikini and Enewetak nuclear weapons tests. Health Phys (2010) 1.42
Psychological distress after the Great East Japan Earthquake and Fukushima Daiichi Nuclear Power Plant accident: results of a mental health and lifestyle survey through the Fukushima Health Management Survey in FY2011 and FY2012. Fukushima J Med Sci (2014) 1.41
Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. Liver Int (2006) 1.40
Exacerbation of autoimmune thyroiditis following bilateral adrenalectomy for Cushing's syndrome. Thyroid (2010) 1.39
Mutations in UVSSA cause UV-sensitive syndrome and impair RNA polymerase IIo processing in transcription-coupled nucleotide-excision repair. Nat Genet (2012) 1.38
Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy. J Mol Cell Cardiol (2005) 1.38
Aurora-B associated protein phosphatases as negative regulators of kinase activation. Oncogene (2002) 1.37
Risk of thyroid cancer in the Bryansk Oblast of the Russian Federation after the Chernobyl Power Station accident. Radiat Res (2004) 1.33
Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab (2004) 1.32
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet (2012) 1.32
miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett (2010) 1.32
Motility and chemotaxis in alkaliphilic Bacillus species. Future Microbiol (2009) 1.31
On the measurement of nicotine dependence in adolescence: comparisons of the mFTQ and a DSM-IV-based scale. J Pediatr Psychol (2005) 1.31
A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control (2003) 1.31
Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J (2008) 1.31
RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. J Clin Endocrinol Metab (2007) 1.31
Pressure overload-induced myocardial hypertrophy in mice does not require gp91phox. Circulation (2004) 1.29
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. Eur J Endocrinol (2003) 1.29
Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection. J Immunol (2008) 1.28
Risk of hematological malignancies among Chernobyl liquidators. Radiat Res (2008) 1.28
Results of EPR dosimetry for population in the vicinity of the most contaminating radioactive fallout trace after the first nuclear test in the Semipalatinsk test site. J Radiat Res (2006) 1.27
Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas. J Clin Endocrinol Metab (2004) 1.27
RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population. J Clin Endocrinol Metab (2004) 1.26
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer. Endocr Relat Cancer (2008) 1.26
Childhood thyroid cancer, radiation dose from Chernobyl, and dose uncertainties in Bryansk Oblast, Russia: a population-based case-control study. Radiat Res (2006) 1.26
BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activation. Endocrinology (2006) 1.25
Acute and chronic intakes of fallout radionuclides by Marshallese from nuclear weapons testing at Bikini and Enewetak and related internal radiation doses. Health Phys (2010) 1.24